These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13873272)

  • 41. Novel C2-purine position analogs of nitrobenzylmercaptopurine riboside as human equilibrative nucleoside transporter 1 inhibitors.
    Gupte A; Buolamwini JK
    Bioorg Med Chem; 2007 Dec; 15(24):7726-37. PubMed ID: 17881236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ACUTE LEUKEMIA IN INFANCY AND CHILDHOOD.
    KLINE CA
    J Am Osteopath Assoc; 1964 Nov; 64():266-79. PubMed ID: 14227412
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical experience using 6-mercaptopurine in childhood leukemia.
    NEWTON WA
    Ann N Y Acad Sci; 1954 Dec; 60(2):468-71. PubMed ID: 14350557
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of cytosine arabinoside, 6-aminonicotinamide, and 6-mercaptopurine riboside on ectoderm and mesoderm of mouse limb buds.
    Krowke R; Berg P; Merker HJ
    Teratology; 1977 Apr; 15(2):137-47. PubMed ID: 141112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-response relationship of teratogenicity and prenatal-toxic risk estimation of 6-mercaptopurine riboside in mice.
    Platzek T; Bochert G
    Teratog Carcinog Mutagen; 1996; 16(3):169-81. PubMed ID: 8983119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Our experience with buthiopurin treatment of acute infantile haemoblastoses.
    HRODEK O
    Neoplasma; 1961; 8():593-9. PubMed ID: 14449489
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparative study of 6-chloropurine and 6-mercaptopurine in acute leukemia in adults.
    ELLISON RR; SILVER RT; ENGLE RL
    Ann Intern Med; 1959 Aug; 51():322-38. PubMed ID: 13820065
    [No Abstract]   [Full Text] [Related]  

  • 48. [LONG-TERM REMISSIONS OF ACUTE LEUKEMIAS IN CHILDHOOD].
    GASSER C
    Med Klin; 1964 Mar; 59():385-93. PubMed ID: 14176488
    [No Abstract]   [Full Text] [Related]  

  • 49. 9-Ethyl-6-mercaptopurine (NSC-14575): preliminary clinical observations.
    JOHNSON CB; FROMMEYER WB; HAMMACK WJ; BUTTERWORTH CE
    Cancer Chemother Rep; 1962 Jul; 20():137-41. PubMed ID: 14452003
    [No Abstract]   [Full Text] [Related]  

  • 50. Letter: TPMT - not all that glitters is gold.
    González-Lama Y; Gisbert JP
    Aliment Pharmacol Ther; 2012 Jul; 36(2):208-9; author reply 209-10. PubMed ID: 22703467
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of two purine analogs on a human tumor in tissue culture.
    FJELDE A
    Z Krebsforsch; 1956; 61(4):364-7. PubMed ID: 13402002
    [No Abstract]   [Full Text] [Related]  

  • 52. [Suppressive effect of thioinosine (6-mercaptopurine riboside) on the production of antibody].
    Ogata M
    Arerugi; 1971 Nov; 20(11):858-65. PubMed ID: 4260240
    [No Abstract]   [Full Text] [Related]  

  • 53. Individualized 6-mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial.
    Tulstrup M; Frandsen TL; Abrahamsson J; Lund B; Vettenranta K; Jonsson OG; Marquart HVH; Albertsen BK; Heyman M; Schmiegelow K
    Eur J Haematol; 2018 Jan; 100(1):53-60. PubMed ID: 28983968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leukemia in children: treatment of 22 cases with 6-mercaptopurine.
    PIERCE M
    Ann N Y Acad Sci; 1954 Dec; 60(2):415-24. PubMed ID: 14350546
    [No Abstract]   [Full Text] [Related]  

  • 55. Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.
    Dervieux T; Hancock ML; Pui CH; Rivera GK; Sandlund JT; Ribeiro RC; Boyett J; Evans WE; Relling MV
    Clin Pharmacol Ther; 2003 Jun; 73(6):506-16. PubMed ID: 12811360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COMPARATIVE CLINICAL TOXICITY OF 6-MERCAPTOPURINE (NSC-755)-1 AND 6-MERCAPTOPURINE RIBONUCLEOSIDE (NSC-4911)-2 ADMINISTERED INTRAVENOUSLY TO PATIENTS WITH ADVANCED CANCER.
    REGELSON W; HOLLAND JF; FREI E; GOLD GL; HALL T; KRANT M; MILLER SO
    Cancer Chemother Rep; 1964 Mar; 36():41-8. PubMed ID: 14152273
    [No Abstract]   [Full Text] [Related]  

  • 57. [Biochemical and clinico-pharmacological aspects of antimetabolites in the treatment of leukemia].
    Bökkerink JP; de Abreu RA; Lippens RJ; Schouten TJ; de Vaan GA
    Tijdschr Kindergeneeskd; 1988 Apr; 56(2):55-60. PubMed ID: 3287684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. METABOLISM OF PURINE NUCLEOSIDE ANALOGS.
    LEPAGE GA; JUNGA IG
    Cancer Res; 1965 Jan; 25():46-52. PubMed ID: 14254993
    [No Abstract]   [Full Text] [Related]  

  • 59. Buthiopurin in the treatment of myelogenic leukaemia.
    KOLAR V
    Neoplasma; 1962; 9():85-91. PubMed ID: 14457953
    [No Abstract]   [Full Text] [Related]  

  • 60. The use of an imidazolyl derivative of thioguanine in acute leukemia.
    ELLISON RR; TAN CT
    Cancer Chemother Rep; 1960 Jul; 8():61-5. PubMed ID: 13820066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.